Vimarsana
Biggest News Aggregation in the World

Decadal Trends News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Decadal Trends. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Decadal Trends Today - Breaking & Trending Today

Gout Statistics: Top Facts & Figures For 2023 - Vimarsana News

Gout Statistics: Top Facts & Figures For 2023

Gout statistics provide insight into the prevalence of this medical condition and who it affects. Learn more in this article.

Shanton Screens First Subjects in Phase 2b Refractory/Tophaceous Gout Study with SAP-001 - Vimarsana News

Shanton Screens First Subjects in Phase 2b Refractory/Tophaceous Gout Study with SAP-001

/PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a groundbreaking treatment for refractory and tophaceous gout patients, today...

Shanton Pharma: Shanton Screens First Subjects in Phase 2b Refractory/Tophaceous Gout Study with SAP-001 - Vimarsana News

Shanton Pharma: Shanton Screens First Subjects in Phase 2b Refractory/Tophaceous Gout Study with SAP-001

SAP-001 is an oral once-a-day investigational gout product with Best-in-Class potential for acute and chronic use in uncontrolled patients BRIDGEWATER, N.J., Jan. 9, 2023 /PRNewswire/ --

Horizon Therapeutics plc Announces First Subject Dosed in Phase 1 Trial Evaluating HZN-457 for the Treatment of Gout - Vimarsana News

Horizon Therapeutics plc Announces First Subject Dosed in Phase 1 Trial Evaluating HZN-457 for the Treatment of Gout

Horizon Therapeutics plc (Nasdaq: HZNP) today announced the first subject has been dosed in a Phase 1 randomized, placebo-controlled trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics